Saba Capital Management, L.P. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$22,682
+17.1%
295,9130.0%0.00%0.0%
Q2 2023$19,368
+63.4%
295,9130.0%0.00%
Q1 2023$11,851
-7.1%
295,9130.0%0.00%
Q4 2022$12,754
-46.9%
295,9130.0%0.00%
Q3 2022$24,000
-22.6%
295,9130.0%0.00%
Q2 2022$31,000
-51.6%
295,9130.0%0.00%
-100.0%
Q1 2022$64,000
-48.4%
295,9130.0%0.00%
-50.0%
Q4 2021$124,000295,9130.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
Atalaya Capital Management LP 225,000$15,7500.02%
Q Global Advisors, LLC 170,785$120.01%
MMCAP International Inc. SPC 375,000$26,8500.01%
PERISCOPE CAPITAL INC. 957,098$68,5280.01%
CVI Holdings, LLC 44,106$3,1580.01%
Silver Rock Financial LP 12,224$8750.01%
Castle Creek Arbitrage, LLC 200,000$14,3200.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 714,827$51,1820.00%
Segantii Capital Management Ltd 5,000$54,3000.00%
GRITSTONE ASSET MANAGEMENT LLC 17,014$1,2180.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders